Complexa, Inc. is a biopharmaceutical company focused on discovering and developing therapies for the treatment of inflammatory and metabolic diseases - initial focus is placed on acute and chronic kidney disease. Complexa's human network pharmacology discoveries have revealed new classes of drug candidates that are based on naturally-occurring activated fatty acids. Their lead compounds activate the body’s own protective mechanisms against inflammatory injury and metabolic stress.

Visit Website: Complexa